Skip to main content
Premium Trial:

Request an Annual Quote

Kapa Biosystems Extends Distribution Pact with Nippon Genetics

NEW YORK (GenomeWeb) — Kapa Biosystems said today that it has signed a three-year exclusive distribution agreement with Nippon Genetics.

The agreement extends an existing seven-year relationship between the companies and enables Nippon to continue marketing, distributing, and servicing Kapa's genomics reagents in Japan.

Kapa, based in Wilmington, Mass., sells reagents for use in PCR, qPCR, next-generation sequencing, and molecular diagnostics. Nippon is headquartered in Tokyo and provides a range of genomic and molecular biology research products for applications such as nucleic acid separation and purification, electrophoresis, PCR, real-time PCR, and NGS library prep.

"We are seeing broad adoption and strong demand for our innovative products not only in Japan, but across the Asia Pacific, European, and North American regions," Jean-Christophe Hatinguais, director of international sales at Kapa Biosystems, said in a statement. "We are now focused on extending our global reach by increasing our strategic investments and expanding our distribution network in key markets."

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.